Category Archives: News

Conference: Inhaled Drug Delivery – from 13 till 14 November in London

Conference: Inhaled Drug Delivery – from 13 till 14 November in London

Management Forum is currently having its 2-day annual conference inhaled drug development. Industry leaders are coming together on November 13 and 14 in London to discuss the current challenges, advancements and possibilities of current inhalation devices and technologies. A lot of attention is also going to the role of patients’ contribution to therapy in adequate… Continue Reading

FLUIDDA’s IPF Catalyst Challenge Entry

FLUIDDA is excited to join the IPF Catalyst Challenge! Functional Respiratory Imaging (FRI) is a very promising tool for early diagnosis, disease staging and progression and as a sensitive biomarker in drug development trials. As part of the challenge we would like to build a framework to enhance patient care through FRI because we believe… Continue Reading

Introduction to Functional Respiratory Imaging (FRI) for Investors and Market Analysts

For those who cannot attend our event coming Thursday at Flanders House in New York, you are welcome to register for the Webcast via following link:       FLUIDDA is delighted to invite you to a dedicated session discussing her proprietary Functional Respiratory Imaging (FRI) technology and its application in drug and device… Continue Reading

ERS Congress 2017 presentation slides downloads

ERS Congress 2017 presentation slides downloads

As the European Respiratory Society Conference has finished, we would like to share the presentation slides and posters FLUIDDA has presented. Please download. If you have any questions, please send us an email or ask a question on Twitter.   Sunday, September 10 Poster Discussions Thematic Posters   Monday, September 11 Oral Presentations Thematic Posters… Continue Reading

CIRO and FLUIDDA join forces in pursuit of better patient care

At the recent European Respiratory Society conference in Milan a collaboration between CIRO and FLUIDDA materialized in an effort to enhance the rehabilitation of COPD patients. The care of COPD patients is challenging due to the vast heterogeneity of the disease. Especially the severe COPD patients are often difficult to manage and require intensive care… Continue Reading

FLUIDDA’s FRI Technology was used in a Positive Phase II Trial with iNOpulse® for Treatment of Pulmonary Hypertension (PH) Associated with Chronic Obstructive Pulmonary Disease (COPD)

“Functional Respiratory Imaging (FRI) provided valuable insights throughout the development process of iNO in COPD patients with PH. The therapy was effective in the initial studies and has great potential to improve the lives of these severely affected patients” Dr. J. De Backer, CEO FLUIDDA   Changes in Blood Vessel Volume determined using Functional Respiratory… Continue Reading